The Trendlines Group (SGX:42T) said its board and audit committee approved investments by related companies of Librae Holdings in its portfolio firms, according to a Friday filing on the Singapore Exchange.
The Librae-related companies, ultimately owned by a trust benefiting British businessman Vincent Tchenguiz, will invest a total of $2.2 million across four Trendlines-backed firms, while Trendlines itself will contribute $850,000.
Trendlines said the investments include $350,000 in Arcuro Medical, $600,000 in IBI AG, $600,000 in Ceretrieve, and $600,000 in Celleste Bio.
The funding will be structured as either share purchase agreements or Simple Agreements for Future Equity (SAFE).
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。